CRVS vs. SAF.PA

Last updated Jun 9, 2026

CRVS (Corvus Pharmaceuticals, Inc.) and SAF.PA (Safran SA) are both stocks. CRVS operates in Biotechnology (Healthcare), while SAF.PA operates in Aerospace & Defense (Industrials). Over the past 10 years, CRVS returned -1.39%/yr vs 18.67%/yr for SAF.PA. At a 0.14 correlation, their price movements are largely independent.

Performance

CRVS vs. SAF.PA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Corvus Pharmaceuticals, Inc. (CRVS) and Safran SA (SAF.PA). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

CRVS is traded in USD, while SAF.PA is traded in EUR. To make them comparable, the SAF.PA values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, CRVS achieves a 44.81% return, which is significantly higher than SAF.PA's 0.94% return. Over the past 10 years, CRVS has underperformed SAF.PA with an annualized return of -1.39%, while SAF.PA has yielded a comparatively higher 18.67% annualized return.

CRVS

• 1D: 0.27%
• 1M: -28.30%
• YTD: 44.81%
• 6M: 30.26%
• 1Y: 185.17%
• 3Y*: 46.04%
• 5Y*: 31.93%
• 10Y*: -1.39%

SAF.PA

• 1D: 2.32%
• 1M: 4.50%
• YTD: 0.94%
• 6M: 3.39%
• 1Y: 16.48%
• 3Y*: 34.81%
• 5Y*: 19.65%
• 10Y*: 18.67%

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRVS vs. SAF.PA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
CRVS Corvus Pharmaceuticals, Inc.	44.81%	43.93%	203.98%	107.06%	-64.73%	-32.30%	-34.56%	48.23%	-64.58%	-27.55%
SAF.PA Safran SA	0.94%	60.85%	26.05%	42.07%	2.59%	-13.17%	-8.31%	30.00%	18.85%	44.82%

Correlation

The correlation between CRVS and SAF.PA is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.13
Correlation (3Y) Calculated over the trailing 3-year period	0.13
Correlation (5Y) Calculated over the trailing 5-year period	0.16
Correlation (10Y) Calculated over the trailing 10-year period	0.14
Correlation (All Time) Calculated using the full available price history since Mar 24, 2016	0.14

Return for Risk

CRVS vs. SAF.PA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRVS

CRVS Risk / Return Rank: 86
CRVS Sharpe Ratio Rank: 74
CRVS Sortino Ratio Rank: 96
CRVS Omega Ratio Rank: 93
CRVS Calmar Ratio Rank: 85
CRVS Martin Ratio Rank: 83

SAF.PA

SAF.PA Risk / Return Rank: 55
SAF.PA Sharpe Ratio Rank: 57
SAF.PA Sortino Ratio Rank: 52
SAF.PA Omega Ratio Rank: 51
SAF.PA Calmar Ratio Rank: 55
SAF.PA Martin Ratio Rank: 58

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRVS vs. SAF.PA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Corvus Pharmaceuticals, Inc. (CRVS) and Safran SA (SAF.PA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CRVS	SAF.PA	Difference
Sharpe ratio: Return per unit of total volatility	1.03	0.50	+0.53
Sortino ratio: Return per unit of downside risk	4.25	0.98	+3.27
Omega ratio: Gain probability vs. loss probability	1.48	1.12	+0.36
Calmar ratio: Return relative to maximum drawdown	3.30	0.67	+2.64
Martin ratio: Return relative to average drawdown	7.42	1.80	+5.62
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CRVS vs. SAF.PA - Sharpe Ratio Comparison

The current CRVS Sharpe Ratio is 1.03, which is higher than the SAF.PA Sharpe Ratio of 0.50. The chart below compares the historical Sharpe Ratios of CRVS and SAF.PA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CRVS	SAF.PA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.03	0.50	+0.53
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.24	0.64	-0.39
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.01	0.53	-0.54
Sharpe Ratio (All Time) Calculated using the full available price history	-0.02	0.45	-0.48

Drawdowns

CRVS vs. SAF.PA - Drawdown Comparison

The maximum CRVS drawdown since its inception was -96.97%, which is greater than SAF.PA's maximum drawdown of -65.85%. Use the drawdown chart below to compare losses from any high point for CRVS and SAF.PA.

Drawdown Indicators

	CRVS	SAF.PA	Difference
Max Drawdown Largest peak-to-trough decline	-96.97%	-65.85%	-31.12%
Max Drawdown (1Y) Largest decline over 1 year	-56.43%	-24.21%	-32.22%
Max Drawdown (3Y) Largest decline over 3 years	-70.50%	-24.21%	-46.29%
Max Drawdown (5Y) Largest decline over 5 years	-92.40%	-41.76%	-50.64%
Max Drawdown (10Y) Largest decline over 10 years	-96.97%	-65.00%	-31.97%
Current Drawdown Current decline from peak	-56.31%	-13.82%	-42.49%
Average Drawdown Average peak-to-trough decline	-69.32%	-13.89%	-55.43%
Ulcer Index Depth and duration of drawdowns from previous peaks	25.07%	9.01%	+16.06%

Volatility

CRVS vs. SAF.PA - Volatility Comparison

Corvus Pharmaceuticals, Inc. (CRVS) has a higher volatility of 23.70% compared to Safran SA (SAF.PA) at 10.60%. This indicates that CRVS's price experiences larger fluctuations and is considered to be riskier than SAF.PA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CRVS	SAF.PA	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.70%	10.60%	+13.10%
Volatility (6M) Calculated over the trailing 6-month period	111.87%	28.77%	+83.10%
Volatility (1Y) Calculated over the trailing 1-year period	181.10%	32.42%	+148.68%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	131.06%	30.36%	+100.70%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	111.16%	34.60%	+76.56%

Dividends

CRVS vs. SAF.PA - Dividend Comparison

CRVS has not paid dividends to shareholders, while SAF.PA's dividend yield for the trailing twelve months is around 1.12%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CRVS Corvus Pharmaceuticals, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SAF.PA Safran SA	1.12%	0.98%	1.04%	0.85%	0.43%	0.40%	0.00%	1.32%	1.53%	0.97%	2.15%	1.96%

Financials

Frequently Asked Questions

Can I hold both CRVS and SAF.PA in my portfolio?

CRVS and SAF.PA have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.